NICE recommends gammaCore for cluster headaches
The portable technology aims to modify pain signals by stimulating the vagus nerve through the skin of the neck.
Read More
Tag: cluster headache
FDA ‘yes’ for Emgality in cluster headache
In a trial, patients taking Emgality experienced 8.7 fewer weekly cluster headache attacks than they did at baseline.
Read More
Lilly files lasmiditan for migraine
Eli Lilly has filed an application in the US to market lasmiditan for the acute treatment of migraine with or without aura in adults.
Read More
Teva pulls fremanezumab cluster headaches trial
Teva is discontinuing a late-stage trial assessing the efficacy of its experimental anti-CGRP therapy fremanezumab in reducing cluster headaches.
Read More
Teva’s anti-CGRP drug under review for migraine
US regulators are now reviewing Teva Pharmaceutical’s experimental anti-CGRP therapy fremanezumab for the preventive treatment of migraine, and have also granted the drug a fast track designation for the prevention of cluster headache.
Read More
AZ divests migraine drug to Grünenthal
AstraZeneca has sold global rights (ex Japan) for its migraine drug Zomig to Grünenthal, as it continues to shed products outside of its area of strategic focus.
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
